Advertisement

The complement system

  • Miroslav Ferenčík
Chapter
  • 128 Downloads

Abstract

Bordet, when working in Pasteur’S laboratory in Paris in 1896, observed that serum of animals immunized with bacteria (Vibrio cholerae), could agglutinate and lyse those bacteria in vitro (either in a test tube or on a slide). If, however, the serum was left at room temperature for one week, or briefly heated at 60 °C, the agglutinating activity remained unchanged but the ability to lyse bacteria was lost. The lytic activity could be restored by adding fresh serum from a non-immunized animal to the bacteria-heated serum mixture. On the basis of this experiment, Bordet assumed that lysis of bacteria required the presence of two factors; specific, agglutinating antibodies (discovered by Behring in 1889) and a non-specific component that was activated secondarily and was responsible for bacterial lysis and killing. Bordet called the latter component “alexin”. Soon after this discovery, particularly when further data were obtained by Ehrlich, the non-specific serum component was renamed “complement”.

Keywords

Systemic Lupus Erythematosus Polypeptide Chain Alternative Pathway Complement System Complement Component 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bashford, C. L., Alder, G. M., Menestrina, G., Micklem, K. J., Murphy, J. J. and Pasternak, C. A. (1986) Membrane damage by haemolytic viruses, toxins, complement and other cytotoxic agents: a common mechanism blocked by divalent cations. J. Biol. Chem. ,261, 9300–8.Google Scholar
  2. Becherer, J. D., Alsenz, J., Servis, C., Myones, B. L. and Lambris, J. D. (1989) Cell surface proteins reacting with activated complement components. Complement Inflamm. ,6, 152–65.Google Scholar
  3. Bhakdi, S. and Tranum-Jensen, J. (1983) Membrane damage by complement. Biochim. Biophys. Acta ,737, 343–72.CrossRefGoogle Scholar
  4. Bhakdi, S. and Tranum-Jensen, J. (1984) Mechanism of complement cytoplysis and the concept of channel-forming proteins. Phil. Trans. R. Soc. Lond. ,B306, 311–24.Google Scholar
  5. Campbell, R. D., Law, S. K. A., Reid, K. B. M. and Sim, R. B. (1988) Structure, organization, and regulation of the complement genes. Annu. Rev. Immunol. ,6, 161–96.CrossRefGoogle Scholar
  6. Di Scipio, R.G. and Hugh, T. E. (1985) The architecture of complement component C9 and poly(C9). J. Biol. Chem. ,260, 14802–9.Google Scholar
  7. Di Scipio, R. G. and Hugli, T. E. (1989) The molecular architecture of human complement component C6. J. Biol. Chem. ,264, 16197–206.Google Scholar
  8. Fries, L. F., O’Shea, J. J. and Frank, M. M. (1986) Inherited deficiencies of complement and complement-related proteins. Clin. Immunol. Immunopathol. ,40, 37–49.CrossRefGoogle Scholar
  9. Hostetter, M. K. and Gordon, D. L. (1987) Biochemistry of C3 and related thiolester proteins in infection and inflammation. Rev. Infect. Dis. ,9, 97–109.CrossRefGoogle Scholar
  10. Hourcade, D. E., Holers, V. M. and Atkinson, J. P. (1989) The regulators of complement activation (RCA) gene cluster. Adv. Immunol. ,45, 381–416.CrossRefGoogle Scholar
  11. Hugh, T. E. (1984) Structure and function of the anaphylatoxins. Springer Semin. Immunopathol.. 7, 193–219.CrossRefGoogle Scholar
  12. Humphrey, J. H. and Dourmashkin, R. R. (1969) The lesions in cell membranes caused by complement. Adv. Immunol. ,11, 75–115.CrossRefGoogle Scholar
  13. Joiner, K. A., Schmetz, M. A., Sanders, M. E., Murray, T. G., Hammer, C. H., Dourmashkin, R. and Frank, M. M. (1985) Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9. Proc. Natl. Acad. Sci. USA ,82, 4802–12. Kay, P. H. and Papadimitriou, J. M. (1990) What’s new in the role of complement in diseases? Pathol. Res. Pract. ,186, 410–4.CrossRefGoogle Scholar
  14. Lachmann, P. J. and Thompson, R. A. (1970) Reactive lysis : the complement-mediated lysis of unsensitized cells. II. The characterization of activation reactor as C6b and the participation of C8 and C9. J. Exp. Med. ,131, 644–57.CrossRefGoogle Scholar
  15. Lambris, J. D. (1988) The multifunctional role of C3, the third component of complement. Immunol. Today ,9, 387–92.CrossRefGoogle Scholar
  16. Mayer, M. M. (1972) Mechanism of cytolysis by complement. Proc. Natl. Acad. Sci. USA ,69, 2954–9.CrossRefGoogle Scholar
  17. Morgan, B. P. (1989) Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem. J. ,264, 1–14.Google Scholar
  18. Müller-Eberhard, H. J. (1984) The membrane attack complex. Springer Semin. Immunopathol., 7, 93–141.CrossRefGoogle Scholar
  19. Müller-Eberhard, H. J. (1988) Molecular organization and function of the complement system. Annu. Rev. Biochem. ,57, 321–347.CrossRefGoogle Scholar
  20. Pasternak, C. A. (1987) Virus, toxin, complement: common actions and their prevention by Ca2+ or Zn2+. BioEssays ,6, 14–19.CrossRefGoogle Scholar
  21. Podack, E. R. and Tschopp, J. (1984) Membrane attack by complement. Mol. Immunol. ,21, 589–603.CrossRefGoogle Scholar
  22. Porter, R. R. (1984) The complement components of the major histocompatibility locus. CRC Crit. Rev. Biochem. ,16, 1–19.CrossRefGoogle Scholar
  23. Preissner, K. T. (1989) The role of vitronectin as multifunctional regulator in the hemostatic and immune systems. Blut ,59, 419–31.CrossRefGoogle Scholar
  24. Reid, K. B. M. and Porter, R. R. (1976) Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem. J. ,155, 19–23.Google Scholar
  25. Ross, G. D. (1989) Complement and complement receptors. Current Opin. Immunol. ,2, 50–62.CrossRefGoogle Scholar
  26. Staršia, Z. (1987) Clinical importance of complement. Prague, Avicenum, pp. 53–95 (in Slovak).Google Scholar
  27. Tschopp, J. and Nabholz, M. (1990) Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu. Rev. Immunol. ,8, 279–302.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1993

Authors and Affiliations

  • Miroslav Ferenčík
    • 1
  1. 1.Institute of Immunology, Faculty of MedicineComenius UniversityBratislavaCzechoslovakia

Personalised recommendations